The goal of Siteman Cancer Center (SCC) Administration is to provide cutting edge research support for investigators, in order to facilitate development and growth of collaborative grants, clinical trials, and publications. SCC Administration supports the 270 SCC members, 8 research programs, 13 cores (11 full and two developing), and research working groups by providing: Administrative oversight of research programs and shared resources Administration of Research Development Award Program (seed grant mechanism) Administration of the SCC membership process Coordination of research seminars, workshops, and retreats Leadership or assistance in developing collaborations between investigators for new research initiatives Planning, coordination, and execution of multi-project research grants (e.g., SPOREs, PPGs) Targeted communication of cancer-related funding opportunities to SCC members Assistance for the SCC Director in recruitment of new faculty Development and management of computer databases and other information systems tools Fiscal management and consultation Space and equipment management Administrative leadership ofthe SCC strategic planning process Management ofthe Cancer Biology Pathway (doctoral training program) within the Division of Biology and Biomedical Sciences Administration of the SCC Summer Opportunities program SCC World Wide Web page development and maintenance

Public Health Relevance

Siteman Cancer Center Administration manages and facilitates the research of the only NCI Comprehensive Cancer Center in the state of Missouri and southern Illinois, with the goal to foster cutting edge, transdisciplinary science to reduce and ultimately eliminate the threat and impact of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA091842-11S1
Application #
8530551
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
11
Fiscal Year
2012
Total Cost
$2,779
Indirect Cost
$951
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Salloum, Naji C; Buchalter, Erica Lf; Chanani, Swati et al. (2018) From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Pharmacogenomics 19:861-871
Aliev, Fazil; Salvatore, Jessica E; Agrawal, Arpana et al. (2018) A Brief Critique of the TATES Procedure. Behav Genet 48:155-167
Mills, Jason C; Samuelson, Linda C (2018) Past Questions and Current Understanding About Gastric Cancer. Gastroenterology 155:939-944
Shepherd, Andrew J; Copits, Bryan A; Mickle, Aaron D et al. (2018) Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain. J Neurosci 38:7032-7057
Dehdashti, Farrokh; Wu, Ningying; Bose, Ron et al. (2018) Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer. Breast Cancer Res Treat 169:523-530
Donabedian, Patrick L; Kossatz, Susanne; Engelbach, John A et al. (2018) Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models. EJNMMI Res 8:59
Groves, Andrew P; Gettinger, Katie; Druley, Todd E et al. (2018) Special Therapy and Psychosocial Needs Identified in a Multidisciplinary Cancer Predisposition Syndrome Clinic. J Pediatr Hematol Oncol :
Andley, Usha P; Tycksen, Eric; McGlasson-Naumann, Brittney N et al. (2018) Probing the changes in gene expression due to ?-crystallin mutations in mouse models of hereditary human cataract. PLoS One 13:e0190817
Sáenz, José B; Mills, Jason C (2018) Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol 15:257-273
Miller, Christopher A; Tricarico, Christopher; Skidmore, Zachary L et al. (2018) A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion. Blood Adv 2:1295-1299

Showing the most recent 10 out of 1244 publications